Screener
BridgeBio Pharma BBIO Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from BridgeBio Pharma’s reported figures.
Based on the most recent quarter.
The source filing: BridgeBio Pharma’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:31 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001743881-26-000019
FAQ
- What is BridgeBio Pharma's book value per share?
- BridgeBio Pharma (BBIO) reported book value per share of -$11.70 in Q1 2026.
- How has BridgeBio Pharma's book value per share changed year-over-year?
- BridgeBio Pharma's book value per share decreased by 34.9% year-over-year, from -$8.67 to -$11.70.
- What is the long-term trend for BridgeBio Pharma's book value per share?
- Over 5 years (2020 to 2025), BridgeBio Pharma's book value per share has grown at a 85.9% compound annual growth rate (CAGR), from $0.49 to -$10.89.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about BridgeBio Pharma's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude